BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance
International Journal of Biological Sciences · 01.01.2025 · 21 (1) · 128-142
DOI: 10.7150/ijbs.99423 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 01.01.2025. Verfasst von Xing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Hernia Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou Universit…. Hauptthemen laut MEDLINE: Ferroptosis, Sorafenib, Proto-Oncogene Proteins B-raf, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Hernia Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001,…
- Department of Ultrasonography, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001, China.
- Department of Nuclear Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001, China.
- Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou City, Fujian Province 350001, China.
Zitieren
APA
Chen, X., Chen, X., Xie, W., Ge, H., He, H., Zhang, A., & Zheng, J. (2025). BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance. International Journal of Biological Sciences, 21(1), 128-142. https://doi.org/10.7150/ijbs.99423
Vancouver
Chen X, Chen X, Xie W, Ge H, He H, Zhang A, et al. BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance. International Journal of Biological Sciences. 2025;21(1):128-142. doi:10.7150/ijbs.99423
BibTeX
@article{Chen2025,
author = {Chen, Xing and Chen, Xiang and Xie, Wenjun and Ge, Hua and He, Hongyan and Zhang, Ailong and Zheng, Junjie},
title = {BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAF V600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance},
journal = {International Journal of Biological Sciences},
year = {2025},
volume = {21},
number = {1},
pages = {128--142},
doi = {10.7150/ijbs.99423}
}
EUVIMED